Skip to main content
Download PDF

In vitro antibacterial and cytotoxic effects of Euphorbia grandicornis Blanc chemical constituents

BMC Complementary Medicine and Therapies volume 22, Article number: 90 (2022) Cite this article

Abstract

Background

Euphorbia grandicornis is widely utilized in traditional medicine for the treatment of microbial infections including sexually transmitted diseases such as syphilis, gonorrhoea and for healing of wounds.

Objective

The aim of this work was to isolate and evaluate the antibacterial and anticancer activities of Euphorbia grandicornis chemical constituents.

Methods

Chemical constituents were isolated and identified using various spectroscopic techniques such as IR, MS, and NMR. The single point growth inhibitory potential of the compounds was determined using a 96-well plate based assay.

Results

The CH2Cl2 crude extracts exhibited potent antibacterial activity against Escherichia coli ATCC 8739 and Staphylococcus aureus ATCC 6538 with percentage growth of 94.90 ± 4.24 and 29.47 ± 4.89 respectively. Hence, the CH2Cl2 crude extract was further subjected to column chromatography which resulted in the isolation of methyl 2,5-dihydroxybenzoate (1), n-octyl benzoate (2), friedelanol (3), and germanicol (4) and identification of compounds 12–24 for the first time in the species based on the LC-MS/MS spectroscopic data. The purified compounds (1–4), and previously reported compounds (5–11) were evaluated for antibacterial activities against S. aureus and E. coli, as well as the cytotoxicity effects against HeLa cells. Of the purified compounds, methyl 2,5-dihydroxybenzoate (1), was the most active against E.coli and S. aureus with a percentage growth of 19.12 ± 0.65 and 23.32 ± 0.23 respectively. β-amyrin (6), and β-sitosterol (8), were active against S. aureus with percentage growth of 27.17 ± 0.07, and 47.79 ± 2.99 respectively.

Conclusion

The results obtained from this study indicate that E. grandicornis, is a rich source of chemical constituents that may provide new lead compounds for the development of antibacterial agents.

Peer Review reports

Introduction

The rising cases of antibiotic resistance and shortage of bioactive antimicrobial drugs remain a major threat to global health [1, 2]. The resistance of pathogens to commercially available drugs possess a major challenge to the attainment of universal health as envisaged in the sustainable development goals on the heath [3, 4]. Bacterial strains like Staphylococcus aureus and Escherichia coli are involved in the many respiratory and skin infections, which cause urogenital, gastrointestinal, and wound contamination, are some of the resistant strains to most of the available antibiotics [5, 6]. Furthermore, the antibiotics commonly used are sometimes associated with adverse side effects such as hypersensitivity, allergic reactions and immune suppression, which makes treatment of bacterial infections difficult [6].

Therefore, there is a need to discover novel therapeutics utilizing naturally occurring lead compounds or pharmacophores from medicinal plants, which can be used to synthesize new antibacterial drugs that are more effective and less toxic. This is because medicinal plants are readily available and are known to synthesize bioactive compounds. In addition, the use of non-toxic natural therapies has achieved success over the past few decades [7]. It is also estimated that 40–60% of the population in developing countries continue to use medicinal plants as complementary medicine in the treatment of infectious and chronic diseases [8]. Medicinal plants used as complementary medicine also showed significant pharmacological properties [9]. Notwithstanding, an ideal chemo-preventive or therapeutic agent for humans should have little or no toxicity, anti-mutagenic, anti-carcinogenic activities; for human cells [9, 10], a known mechanism of actions, the capability of consumption orally, readily available, affordable, and human acceptance. All which plants and their constituents have proved to possess. Therefore, plants could provide lead compounds for drug discovery, particularly as antibacterial agents [10].

The wide distribution of Euphorbia species in Africa and their different forms of growth have attracted human interest since ancient times and are utilized in the treatment of several illnesses [11,12,13]. Reported literature shows that most species are used in traditional medicine for the treatment of diseases ranging from microbial and respiratory infections, body and skin irritations, digestion complaints, inflammation, body pain, snake and scorpion bites, nutritional disorders to endocrine disorders and pregnancy or birth disorders [11, 12, 14, 15]. Many records described the use of Euphorbia species for the treatment of microbial infections including sexually transmitted diseases such as syphilis and gonorrhoea. Other medicinal uses include tuberculosis, ringworms, malaria, and anthelmintic [11, 12].

The extracts of these species were reported to possess antibacterial, anti-inflammatory, antioxidant, antitumor, antispasmodic, antidiabetic, ant-eczema, antitussive, and anti-proliferative properties [12, 13]. The diverse medicinal uses of Euphorbia species are often related to the presence of bioactive compounds like macrocyclic and polycyclic diterpenoids. For instance, ent-abietane diterpenoids isolated from roots extracts of E. wallichii were evaluated for antimicrobial activity against six Gram-positive bacteria including Eorynebacterium (T25–17), Enterococcus species (8152), Enterococcus faecalis (C159–6), and Gram-negative bacteria including Citrobacter freundii (11041), Acinetobacter baumanii (9010) and A. baumanii (9011) using gentamicin as a positive control. 11β-hydroxy-14-oxo-17-al-ent-abieta-8(9),13(15)-dien-16,12β-olide,11β,17-dihydroxy-12-methoxy-ent-abieta-8(14), 13(15)-dien-16,12A-olide and 14A-hydroxy-17-al-entabieta-7(8),11(12), 13(15)-trien-16,12-olide were found to exhibit significant antimicrobial activities against the three Gram-positive bacteria with MIC value of 60.00 μg/mL but they were inactive against the Gram-negative bacteria as compared to gentamicin as the control [16]. However, among the Euphorbia species, Euphorbia grandicornis Blanc is one of the unexplored species that is native to the African continent where it is cultivated for its use in the treatment of antimicrobial infections and wound healing [17]. The current research was therefore aimed at investigating the antibacterial constituents of Euphorbia grandicornis Blanc.

Materials and methods

General

Column chromatography was performed on polyamide columns (5 × 60 cm, 200 g) (Germany GmbH) over silica gel (Kieselgel 60 GF254, 15 μm, Merck, Germany). While Thin Layer Chromatography (TLC) was carried out on Kieselgel 60 F254 (Merck). Spots on UV active silica gel were detected under UV light (245 and 336 nm) and made visible using a concentrated sulphuric-anisaldehyde spray mixture and heated at 105 °C for 2 min.

All the NMR experiments were performed on a Bruker Avance spectrometer (Bruker spin AG, DRX, Switzerland 400.13 MHz; 100.62 MHz). All spectral data were referenced to solvent peaks (CDCl3, δH: 7.25, δC: 77.24 ppm recorded at 25 °C. Melting points was determined on an Ernst LeitzWetziar micro-hot stage melting point apparatus and were reported uncorrected. IR spectra were measured on PerkinElmer spectrometer, version 10.54 and the absorptions were recorded in wavenumbers (cm − 1).

The specific optical rotation was performed using Jasco P-2000 polarimeter (JASCO, Germany) using a 10 cm length. The High-Resolution LC-MS analysis was performed on a Bruker Daltonics Compact QTOF Mass Spectrometer in the positive mode. The 5 min run was achieved using an Acclaim RSLC 120 C18, 2.2 μm, 2.1 × 100 mm (P/N 068982) column at 40 °C, flow rate 0.2 ml/min. The solvent system used was Water-Acetonitrile (10:90, v/v) each solvent containing 0.1% of formic acid [18, 19].

The liquid chromatography-mass spectrometry (LC-MS), with a Waters Synapt G2 quadrupole time-of-flight (QTOF) mass spectrometer (MS), connected to a water ultra-performance liquid chromatography (UPLC) (Waters, Milford, MA, USA) was used for the analysis of the crude extracts. Electrospray ionization was used in negative mode with a cone voltage of 15 V, desolvation temperature of 275 °C, gas at 650 L/h, and the rest of the MS settings optimized for best resolution and sensitivity. Data were acquired by scanning from m/z 150 to 1500 m/z in resolution mode as well as in MSE mode. In MSE mode two channels of MS data were acquired, one at low collision energy (4 V) and the second using a collision energy ramp (40–100 V) to obtain fragmentation data as well. Leucine enkaphalin was used as lock mass (reference mass) for accurate mass determination and the instrument was calibrated with sodium formate [18]. The analysis was done at Stellenbosch University, LC-MS unit.

Plant material

The roots and aerial parts of Euphorbia grandicomita plants were collected in summer at the Limpopo province, Wild flowers nursery, South Africa, S 05°04.579′ E 043°35.035′, in November 2017. The plant specimen was identified by Erich Van Wyk, at the South African National Biodiversity Institute (SANBI), Pretoria, South Africa and the specimen was deposited with a voucher number of 18,044 [19].

Extraction and isolation

The fresh aerial (969.72 g) and roots (800.34 g) of E. grandicomita were chopped, dried, and separately percolated with dichloromethane (CH2Cl2) (2.5 L) at room temperature for 2 weeks. The CH2Cl2 extract was then concentrated under reduced pressure on a rotary evaporator to obtain the crude extracts. Fractionation of the root extract (23.5 g) resulted in 200 fractions of eluents, collected in 250 mL aliquots which were subsequently concentrated and subjected to TLC analysis. The TLC profiling of the aliquots resulted in the combination of fractions 1–49 (200.22 mg) eluted with 100% n-hexane as a fraction (FO). Similarly, TLC analysis of fractions 50–100 (fractions; 50–60 (n-hexane: CH2Cl2; 9:1 v/v) and 61–100; (n-hexane: CH2Cl2; 8:2 v/v) showed four spots of retention factor (Rf) values of 0.53 (major component), 0.52, 0.45 and 0.58, which turned purple on staining with anisaldehyde-conc.H2SO4 mixture and subsequent heating at 100 °C. The fractions were combined as FA (200.45 mg) and was further purified (n-hexane: CH2Cl2; 9: 0.5 v/v) to yield white crystals of friedelanol (3) (Rf = 0.53, 7.24 mg) which was collected as sub fractions 1–30. Sub fractions 51–70 were also combined and further purified using n-hexane: CH2Cl2; 8:2 v/v, to yield a white powder of germanicol (4) (Rf = 0.42, 10.32 mg). The mother liquor and sub-fractions 85–92 were combined and evaporated under reduced pressure on a rotary evaporator. Preparative TLC chromatography of this fraction using (n-hexane: EtOAc; 98:2 v/v) afforded white powder of n-octyl benzoate (2), (13.42 mg, Rf = 0.42). Furthermore, fractions 101–180 (Fractions 101–120 (n-hexane: CH2Cl2; 7:3 v/v) and fractions 121–180 (n-hexane: CH2Cl2; 2:8 v/v) had two main compounds having Rf values of 0.34 and 0.35 together with other minor compounds when developed in n-hexane: CH2Cl2; 1:1 v/v solvent mixture. The fractions were pooled together to form fraction FB (180.43 mg). Column chromatography of fraction FB gave 100 subfractions of 20 mL each. TLC analysis led to the combination of subfractions 1–50 which was dried out to give white powder of methyl 2,5-dihydroxybenzoate (1), (n-hexane:EtOAc; 3:7 v/v, Rf = 0.58, 8.12 mg).

Antibacterial activities and cytotoxicity

The single point growth inhibitory potential of the samples was determined using a 96-well plate based assay. The bacterial strains used in this assay included Escherichia coli (ATCC 25922), and Staphylococcus aureus (ATCC 25923). HeLa cells were used to evaluate the cytotoxicity of the compounds. Overnight cultures of bacterial strains were maintained on Luria Agar plates streaked to single colonies and stored at 4 °C and were grown on liquid cultures in 5 mL Luria Broth test tubes. A single colony was selected using a sterile toothpick and were suspended in 5 mL LB medium and incubated on a shaker at 160 rpm overnight at 37 °C. Thereafter, 50 μL of overnight bacterial suspension was aspirated into a 5 mL of sterile LBM and was grown to log phase on a shaker (160 rpm) at 37 °C. Samples were reconstituted in dimethyl sulfoxide (DMSO) to a stock concentration of 20 mg/mL, and tested at a final concentration of 50 μg/mL. About 20 μL of 0.5 mg/mL of the extract and 20 μL bacterial suspension (1:100 E. coli; 1:10 S. aureus) were made to a final volume of 200 μL by addition of 160 μL LBM and the plates were incubated at 37 °C for 6 h in sealed plastic to avoid evaporation. Negative control 0% media only, no cells, and positive control 100% cells plus media (no extract) were used. To assess the percentage of cell viability, a resazurin viability reagent (20 μL of resazurin) was used. After the plates were scored visually, 20 μL of the prepared viability reagent was added to each well and the plates were incubated for an additional 20–60 min. This was followed by measuring the mean fluorescence intensity on a PerkinElmer Enspire microplate reader with the excitation/emission wavelengths set to 560/590 nm. The % bacterial growth was calculated using the following equation:

$$\%\mathrm{Bacterial}\ \mathrm{growth}=\frac{\mathrm{Sample}\ \mathrm{FI}-\Sigma \mathrm{blank}}{\Sigma \mathrm{negative}\ \mathrm{control}-\Sigma \mathrm{blank}} \times 100$$

To assess the cytotoxicity, compounds were incubated at a fixed concentration of 50 μg/mL in 96-well plates containing HeLa cells for 24 h. The numbers of cells surviving drug exposure were determined by using the resazurin-based reagent and reading resorufin fluorescence in a multiwell plate reader in compound-treated wells relative to untreated controls. The results were expressed as % cell viability, based on fluorescence reading in treated wells versus the untreated control well and measurements were done in triplicate.

Isolated compounds

Repeated column chromatography and preparative thin-layer chromatography of E. grandicornis Blanc root extract afforded methyl 2,5-dihydroxybenzoate (1), n-octyl benzoate (2), β-friedelanol (3), and germanicol (4) for the first time in the species alongside (5–11) previously reported compounds [19] (Fig. 1).

Fig. 1
figure 1

Chemical structures of isolated compounds from E. grandicornis Blanc

Full size image

Methyl 2,5-dihydroxybenzoate (1) was obtained from the CH2Cl2 extract of E. grandicornis as a white powder. The melting point was determined to be between 78 and 89 °C with its specific optical rotation recorded as [α]D25–75.53 (CHCl3, conc = 6.60 (w/v%) at 20 °C. The HR-ESI-MS exhibited a pseudo-molecular ion [M + H]+ at m/z 169.0107 which indicated a molecular formula C8H8O4 calculated for m/z 168.0423. The IR spectrum displayed absorptions bands at 2957.8 cm− 1 which revealed the presence of C = C and absorptions at 1214 cm− 1 due to C-O stretches of the methoxy group. Broad absorption bands at 3244 cm− 1 were attributed to the hydroxyl groups (OH). The 1H NMR (400 MHz) displayed a characteristic singlet peak of a methoxy with proton resonance at δH 3.94 (s, H-7) ppm, integrating to three protons. The spectrum also displayed aromatic protons at δH 6.93 (d, J = 12.0, H-5) and 7.29 7.41 (d, J = 1.7, H-3, H-6) ppm. The 13C NMR spectrum showed eight carbon resonances at δC 122.9 (C-1), 156.7 (C-2), 114.8 (C-3), and 118.5 (C-4) ppm. The spectrum also displayed a carbonyl resonance at δC 167.4 and a methoxy carbon resonance at δC 52.4 ppm. The NMR spectral data compared well with a known compound named; methyl 2,5-dihydroxybenzoate, previously isolated from Illicium dunnianum as in Tables S1 and S2 [20].

n- Octylbenzoate, (2) was obtained from the CH2Cl2 extracts of E. grandicornis as a pure white powder. The melting point was determined between 75 and 95 °C with its optical specific rotation recorded as [α]D + 54.10 (CHCl3, conc = 3.6 (w/v%) at 25 °C. The HR-ESI-MS spectrum showed a pseudo-molecular ion [M + H]+ at m/z 235.0723, calculated for C15H22O2, m/z 234.1620. The fragmentation patterns were consistent with that of a monosubstituted benzoate ester with a molecular peak at [M + H]+ = 116.1248 (C8H17)+ due to an octyl side-chain molecular ion, and at [M-H]+ m/z 123.0574 (C7H6O2)+ due to benzoic acid molecular ion. The IR spectrum exhibited an absorptions band at 1718 cm− 1 which revealed the presence of a carbonyl group, absorption band at 1107 cm− 1 due to C-O stretches and more absorption bands at 2913 cm− 1 and 2860 cm− 1 attributed to C-H (alky) stretches.

The 1H NMR (400 MHz) displayed characteristic signals of a benzoate ester with proton resonances at δH 8.02 (d, J = 7.2, H-2, H-6), 7.52 (t, J = 7.6, H-4, H-5) and 7.44 (d, J = 6.4, H-3) ppm. The spectrum exhibited a triplet proton resonance at δH 4.31 (t, J = 6.8) ppm. In addition, an upfield triplet proton resonance at δH 0.83 (t, J = 6.8, H-9′) ppm was attributed to the terminal methyl group, while a broad clustered proton resonance at δH 1.22 ppm accounted for twelve protons revealing the presence of six methylene groups. The 13C NMR spectrum displayed carbon resonances typical of a benzoate ester (δC; 128.3, 129.5, 130.5, 132.7) [21], however, attached with an aliphatic side chain. The NMR spectral data for compound (2) were consistent with the synthetically reported n-octyl benzoate as in Tables S1 and S2 [22].

3 β -friedelanol, (3) was isolated as a white crystal. The melting point was determined to be between 192 and 197 °C while its optical rotation was determined to be [α]D25 + 34.20 (CHCl3, conc = 0.36 (w/v%). The HR-ESI-MS spectrum for this compound displayed a pseudo-molecular ion [M + H]+ at m/z 429.1763 indicating a molecular formula C30H52O calculated for m/z 428.7333. The IR spectrum exhibited absorption bands at 3340 cm− 1 due to the hydroxyl group and bands at 2925 and 2866 cm− 1 were ascribed to C-H stretches. Analysis of the 1H NMR (400 MHz) spectra displayed resonances due to an oxymethine proton at δH 3.66 (t, J = 1.9, 1H) ppm which correlated with a carbon resonance at δC 72.8 (C-3) ppm as observed in the HSQC spectrum. Other observed methyl proton resonances were δH 0.97 (s, 3H-23), 1.11 (s, 3H-24), 0.93 (s, 3H-25), 0.97 (s, 3H-26), 1.01 (s, 3H-27), 1.00 (s, 3H-30), 1.17 (s, 3H-28) and 0.89 (s, 3H-29) ppm. Based on the NMR data and by comparison to literature values as shown in Tables S1 and S2, compound (3) was identified to be 3β-friedelanol (3) [23, 24].

Germanicol, (4) was isolated from the CH2Cl2 root extract of E. grandicornis as a white powder. The 1H NMR (400 MHz) spectrum presented singlets proton resonances due to eight methyl signals at δH (ppm); 0.78 (3H-24), 0.78 (3H-30), 0.82 (3H-28), 0.86 (3H-29), 1.00 (3H-23), 0.78 (3H-25), 0.95 (3H-26), 1.01 (3H-27), this was further confirmed by 13C NMR spectrum. In addition, it displayed proton signals between δH 1.12–2.01 ppm attributed to methine and methylene proton signals. The NMR spectral data and literature values as shown in Tables S1 and S2 confirmed the structure of the compound as germanicol [25,26,27].

Identified compounds using LC-MS/MS

In this study, the phenolic profiling of CH2Cl2 aerial and root crude extracts of E. grandicornis was analyzed using LC-MS/MS in the positive and negative modes. The identification of compounds was based on the accurate comparison of MS profiles with the available reference standard, accurate mass, MS/MS fragmentation patterns, relative retention times, and by comparison with the literature data. Flavonoids (14-24) were detected as major components in the analyzed aerial extract of E. grandicornis. Diterpenes of phorbol esters; 16-angeloyloxy-13R-isobutanoyloxy-4β,9R,7β-trihydroxytiglia-1,5-dien-3-one (12), 16-angeloyloxy-13α-isobutanoyloxy-4β,9α-dihydroxytiglia-1,6-dien-3-one (13) and ingenol (16), were also identified. The identified flavonoids include apegenin (14), catechin (15), kaempferol 3-O-(2″-O-α-rhamnosyl-6″-O-malonyl)-β-glucoside (17), kaempferol-O-glucosides (18), kaempferol-O-rutinoside (19), luteolin-O-glucoside (20), luteolin (21), quercetin (22), quercetin-O-hexoside (23), and rumarin (quercetin-O-pento hexoside) (24), (Table 1, Fig. 2). Quercetin, quercetin-3-O-α-L-rhamnoside, and kaempferol-3-O-α-L-rhamnoside were previously isolated from E. formosana and apigenin-7-glucoside from E. prostrata [28].

Table 1 LC-MS/MS spectral data of compounds identified from crude extracts of Euphorbia grandicornis Blanc
Full size table
Fig. 2
figure 2

Structures of identified compounds from Euphorbia grandicornis Blanc crude extracts by LC-MS/MS

Full size image

The LC-MS chromatogram displayed a major peak [M-H]+ at m/z 593.1503 with a retention time of 18.08 min [Supplementary material (LC-MS2)]. These values were consistent with the theoretical molecular mass of kaempferol-O-rutinoside (19) and hence the peak was assigned to the known compound [29, 32]. The fragmentation patterns [M + H]+ observed at m/z 284.0309 (attributed to the loss of CH3), 285.0367, and 227.0314 were in agreement with that of the standard reference. Besides, the molecular ion peak [M-H]− at m/z 447.0910 [Supplementary Material (LC-MS3)] with an MS fragmentation ion at m/z 285.0367 and which was consistent with the reference standard, was assigned as kaempferol-O-glucoside (18) [29]. These flavonoids were the most abundant phenolic compounds in the aerial crude extract.

The peak [M-H]− at m/z 463.1227 [Supplementary Material (LC-MS4)] was assigned as quercetin-O-hexoside (23). The LC-MS spectral data of quercetin-O-hexoside agreed with the previously reported quercetin hexoside by Hussein et al. [36]. Moreover, a molecular ion peak [M-H]− at m/z 289.0690 with a fragmentation molecular ion at m/z 230.1216 and m/z 279.1215 and retention time 17.13 min [Supplementary Material (LC-MS6)] was assigned as (+)-catechin (15) previously identified in Argan fruits. The fragmentation pattern was observed, and its retention time was comparable with the reference standard and with the theoretical data for catechin. The observed peak [M + H]+ at m/z 449.2012 and the fragmentation patterns [Supplementary Material (LC-MS6)] helped to assign this peak to luteolin-O-glucoside (20), previously isolated from thyme by [33] and identified from Chrysanthemum flower. The MS data were consistent with the reported compound.

In addition, a major molecular peak [M + H]+ at m/z 697.1594 (for C30H32O19) with a retention time of 16.26 min [Supplementary material (LC-MS5)] was attributed to a flavonoid glycoside kaempferol 3-O-(2″-O-α-rhamnosyl-6″-O-malonyl)-β-glucoside (17), a rhamnosyl flavonoid previously isolated from Clitoria termatea [31]. The fragmentation pattern for this compound at m/z 301.0325 was consistent with the theoretical MS data for the compound.

Antibacterial activities isolated compounds

This study revealed that the CH2Cl2 extract had antibacterial activities against Escherichia coli ATCC 8739 and Staphylococcus aureus ATCC 6538 with a percentage growth of 94.90 ± 4.24 and 29.47 ± 4.89 μg/mL respectively. Table 2 shows the percentage growth of S. aureus, E. coli, and HeLa cells on exposure to crude extracts and pure compounds.

Table 2 Percentage growth of S. aureus, E. coli, and HeLa cells on exposure to 50 μg/mL of the isolated compounds
Full size table

The extract was more active against S. aureus indicating selective activity with a percentage growth of 94.90 ± 4.24 and 29.47 ± 4.89 against E. coli and S. aureus respectively. The results are in agreement with the previous studies which showed significant antibacterial activities of E. royleana hexane extracts [37]. The extract exhibited antibacterial activity against the Gram-positive bacteria Bacillus subtilis [38]. Antibacterial evaluation of extracts from E. guyoniana showed significant activities against strains used with percentage growth values ranging from 1.47 to 61.78 mg/mL in the order of Staphylococcus aureus > Streptococcus faecalis > Escherichia coli [38].

Among the tested compounds, Methyl 2,5-dihydroxybenzoate (1), was the most active against E.coli and S. aureus with percentage growth values of 19.12 ± 0.65 and 23.32 ± 0.23 μg/mL respectively. β-amyrin (6), and β-sitosterol (8), were active against S. aureus with percentage growth values of 27.17 ± 0.07, and 47.79 ± 2.99 μg/mL respectively. Other compounds exhibited some antibacterial activities with percentage growth values ranging from 51.94 ± 15.59 to 83.57 ± 4.45 for S. aureus and from 79.10 ± 1.36 to 132.55 ± 2.16 for E. coli as presented in Table 2 and Fig. 3.

Fig. 3
figure 3

Percentage growth of S. aureus, E. coli and Hela cells

Full size image

It was interesting to note that stigmasterol (7), (24R)-tirucalla-8,25-diene-3β, 24-diol (9), and euphorbol (10) exhibited cytotoxic activities against HeLa cells with values of 15.24 ± 0.26, 18.81 ± 2.02 and 50.57 ± 11.29 respectively, as illustrated in Fig. 3.

In related studies, evaluation of compounds isolated from E. tirucalli exhibited significant antibacterial activities of the extracts against S. aureus (ATCC 6538), S. brasiliensis (UFPE 121), and E. coli (ATCC 8739), with minimum inhibition concentration (MIC) values ranging from 256 to 1024 μg/mL. Of the tested compounds, ampelopsin showed a MIC value of 16 μg/mL against E. coli (ATCC 8739), compared to tetracycline (MIC value of 32 μg/mL) [39]. Equally, the evaluation of hexane extract of E. royleana displayed significant antimicrobial activities [37].

Conclusions

Chromatographic analysis of Euphorbia grandicornis Blanc crude extracts afforded twenty-four compounds (1-24). Compounds (1-4) were reported for the first time from the species. Methyl 2,5-dihydroxybenzoate (1) displayed good antibacterial activities against E. coli and S. aureus with a percentage growth of 19.12 and 23.32 at 50 μg/mL respectively. The results obtained from this study shows that E. grandicornis, is rich source of chemical constituents that may provide new lead compounds for the development of antibacterial agents.

Availability of data and materials

All data generated or analysed during this study are included in this published article [and its supplementary information files].

References

  1. Theuretzbacher U, Mouton JW. Update on antibacterial and antifungal drugs - can we master the resistance crisis? Curr Opin Pharmacol. 2011;11:429–32 https://doi.org/10.1016/j.coph.2011.08.002.

    Article  CAS  Google Scholar 

  2. Walsh TR, Toleman MA. The emergence of pan-resistant gram-negative pathogens merits a rapid global political response. J Antimicrob Chemother. 2012;67:1–3 https://doi.org/10.1093/jac/dkr378.

    Article  CAS  Google Scholar 

  3. Awouafack MD, Mcgaw LJ, Gottfried S, Mbouangouere R, Tane P, Spiteller M, et al. Antimicrobial activity and cytotoxicity of the ethanol extract, fractions, and eight compounds isolated from Eriosema robustum (Fabaceae). BMC Complement Altern Med. 2013;13 https://doi.org/10.1186/1472-6882-13-289.

  4. Srivastava J, Chandra H, Nautiyal AR, Kalra SJS. Antimicrobial resistance (AMR) and plant-derived antimicrobials (PDAms) as an alternative drug line to control infections. Biotech. 2014;4:451–60 https://dx.doi.org/10.1007%2Fs13205-013-0180-y.

    Google Scholar 

  5. Levin S. The crisis in antibiotic resistance. Infect Dis Clin Pract. 1993;2:53.

    Article  Google Scholar 

  6. Torgersen H, Lassen J, Jelsoe E, Rusanen T, Nielsen TH. Antimicrobial resistance: the example of SA. J Biolaw Bus. 2000;3:53–9.

    Google Scholar 

  7. Saleem H, Zengin G, Locatelli M, Mollica A, Ahmad I, Mahomoodally FM, et al. In vitro biological propensities and chemical profiling of Euphorbia milii des Moul (Euphorbiaceae): a novel source for bioactive agents. Ind Crop Prod. 2019;130:9–15 https://doi.org/10.1016/J.INDCROP.2018.12.062.

    Article  CAS  Google Scholar 

  8. Fridlender M, Kapulnik Y, Koltai H. Plant-derived substances with anti-cancer activity: from folklore to practice. Front Plant Sci. 2015;6:1–9 https://dx.doi.org/10.3389%2Ffpls.2015.00799.

    Article  Google Scholar 

  9. Grochowski DM, Uysal S, Zengin G, Tomczyk M. In vitro antioxidant and enzyme inhibitory properties of Rubus caesius. Int J Environ Health Res. 2018;12:1–9 https://doi.org/10.1080/09603123.2018.1533532.

    Google Scholar 

  10. Prasad S. Traditional medicine: the goldmine for modern drugs. Adv Tech Bio Med. 2015;3:1–2 https://doi.org/10.4172/2379-1764.1000E108.

    Google Scholar 

  11. De montellano BO. Empirical Aztec medicine. Science. 1975;188:215220.

  12. Hooper M. Major herbs of Ayurveda. Elsevier Health Sciences, Elsevier, the Netherlands, 2000;340–345.

  13. Mwine JT, Van Damme P. Why do Euphorbiaceae tick as medicinal plants? A review of the Euphorbiaceae family and its medicinal features. J Med Plant Res. 2011;5:652–62.

    Google Scholar 

  14. Ernst M, Grace OM, Saslis-lagoudakis CH, Nilsson N, Simonsen HT, Rønsted N. Global medicinal uses of Euphorbia L. (Euphorbiaceae). J Ethnopharmacol. 2015;176:90–101 https://doi.org/10.1016/j.jep.2015.10.025.

    Article  Google Scholar 

  15. Esposito M, Nim S, Nothias L, Gallard J, Rawal MK, Costa J, et al. Evaluation of jatrophane esters from Euphorbia species as modulators of Candida albicans multidrug transporters. J Nat Prod. 2017;34:435–8 https://doi.org/10.1021/acs.jnatprod.6b00990.

    Google Scholar 

  16. He L, Peng Y, En-Hui Z, Ling-Man K, Chun-Yuan M. Antimicrobial ent-abietane-type diterpenoids from the roots of Euphorbia wallichii. J Asian Nat Prod Res. 2020:1–9 https://doi.org/10.1080/10286020.2020.1758931.

  17. Aditya S. A revision of geophytic Euphorbia species from India. Euphorbia World. 2010;6:18–21.

    Google Scholar 

  18. Rautenbach M, Vlok M, Eyeghe-bickong HA, Van Der merwe MJ, Stander MA. An electrospray ionization mass spectrometry study on the “in vacuo” hetero-oligomers formed by the antimicrobial peptides, surfactin, and gramicidin. Anal. J. Am. Soc. 2017;28:1623–1637. https://doi.org/10.1007/s13361-017-1685-0.

  19. Magozwi DK, Xolani P, Langat MK, Mhlanga R, Vukea N, Jo-Anne de la Mare, Siwe-Noundou X, Rui WMK, Tembu VJ. In vitro cytotoxic effects of chemical constituents of Euphorbia grandicornis Blanc against breast cancer cells, Sci Afr 2021;14:1–8. https://doi.org/10.1016/j.sciaf.2021.e01002.

  20. Di G, Lianjin W, Yuanyuan H, Xin Y. Chemical constituents from Illicium dunnianum. Adv Mater Res. 2012;553:1586–9 https://doi.org/10.4028/www.scientific.net/AMR.550-553.1586.

    Article  Google Scholar 

  21. Parmar VS, Bisht KS, Malhotra A, Jha A, Errington W, Howarth OW, et al. A benzoic acid ester from Uvaria narum. Phytochemistry. 1995;38:951–5 https://doi.org/10.1016/00319422(94)00732-9.

    Article  CAS  Google Scholar 

  22. Klara C, Bojan B, Stojan S. Esterification of aryl/alkyl acids catalyzed by N-bromosuccinimide under mild reaction conditions. Molecules. 2018;23:2235 https://doi.org/10.3390/molecules23092235.

    Article  Google Scholar 

  23. Salazar GCM, Silva GDF, Duarte LP, Vieira SA, Lula IS. Two epimeric friedelane triterpenes isolated from Maytenus truncata: 1H and 13C chemical shift assignments. Magn Reson Chem. 2000;38:977–80 https://doi.org/10.1002/1097-458X(200011)38:11%3C977::AID-MRC757%3E3.0.CO;2-9.

    Article  CAS  Google Scholar 

  24. Ragasa CY, Caro JL, Shen C. Chemical constituents of Artocarpus ovatus. Dert Pharma Chemica. 2015;7:178–82.

    CAS  Google Scholar 

  25. Gonzalez AG, Fraga BM, Gonzalez P, Hernandez MG. 13C NMR spectra of Olean-18-ene derivatives. Phytochemistry. 1981;20:1919–21.

    Article  CAS  Google Scholar 

  26. Tori M, Tsuyuki T, Takahashi T. Backbone rearrangement of 3β, 4β-epoxifriedelanen: a formation of germanicol and solvent effects. Bull Chem Soc Jpn. 1977;12:3381–3 https://doi.org/10.1246/bcsj.50.469.

    Article  Google Scholar 

  27. Zhou SY, Li RT, Li HM, Zheng H. Study on chemical constituents of Kadsura interior. J Kunming Univ Sci Technol. 2008;33:81–5.

    CAS  Google Scholar 

  28. Sarika D, Monica S, Anu M, Shruti R, Nipun M. A rapid densitometric method for the quantification of apigenin-7-glucoside in Euphorbia prostrata herb using HPTLC. J Pharm Res. 2012;5:859–61.

    Google Scholar 

  29. Forgo F, Dora R, Zsanett H, Pal S, Laszlo S, Judit H. Unusual tigliane diterpenes from Euphorbia grandicornis. J Nat Prod. 2011;74:639–43 https://doi.org/10.1021/np100673s.

    Article  CAS  Google Scholar 

  30. Ulubelen A, Öksüz S, Halfon B, Aynehchi Y, Mabry TJ. Flavonoids from Euphorbia larica, E. virgata, E. chamaesyce, and E. magalanta. J Nat Prod. 1983;46:598 https://doi.org/10.1021/np50028a037.

    Article  CAS  Google Scholar 

  31. Kazuma K, Noda N, Suzuki M. Malonylated flavonol glycosides from the petals of Clitoria ternatea. Phytochemistry. 2003;62:229–37 https://doi.org/10.1016/s0031-9422(02)00486-7.

    Article  CAS  Google Scholar 

  32. Martins N, Barros L, Santos-buelga C, Silva S, Ferreira ICFR. Decoction, infusion, and hydroalcoholic extract of cultivated thyme: antioxidant and antibacterial activities, and phenolic characterization. Food Chem. 2015;167:131–7 https://doi.org/10.1016/j.foodchem.2014.06.094.

    Article  CAS  Google Scholar 

  33. Nagy TO, Solar S, Sontag G, Koenig J. Identification of phenolic components in dried spices and influence of irradiation. Food Chem. 2011;128:530–4 https://doi.org/10.1016/j.foodchem.2011.03.037.

    Article  Google Scholar 

  34. Wang Y, Yu X, Wang L, Zhang F, Zhang Y. Research progress on chemical constituents and anticancer pharmacological activities of Euphorbia lunulata Bunge. Biomed Res Int. 2020:1–11 https://doi.org/10.1155/2020/3618941.

  35. Ferran S, Olga J, Rosa M, Lamuela-ravento F, Viladomat J, Carles C. Qualitative analysis of phenolic compounds in apple pomace using liquid chromatography coupled to mass spectrometry in tandem mode. Rapid Commun Mass Spectrom. 2004;18:553–63 https://doi.org/10.1002/rcm.1370.

    Article  Google Scholar 

  36. Hussein M, Roby H, Atef M, Selim KA, Ibrahim K. Evaluation of antioxidant activity, total phenols, and phenolic compounds in thyme (Thymus vulgaris L), sage (Salvia officinalis L), and marjoram (Origanum majorana L) extracts. Ind Crop Prod. 2013;43:827–31 https://doi.org/10.1016/j.indcrop.2012.08.029.

    Article  Google Scholar 

  37. Ashraf A, Sarfraz RA, Rashid MA, Shahid M. Antioxidant, antimicrobial, antitumor, and cytotoxic activities of an important medicinal plant (Euphorbia royleana) from Pakistan. J Food Drug Anals. 2005;23:109–15 https://doi.org/10.1016/j.jfda.2014.05.007.

    Article  Google Scholar 

  38. Boumaza S, Bouchenak O, Yahiaoui K, Toubal S, EL Haddad D, Arab K. Effect of the aqueous extract of Euphorbia guyoniana (Euphorbiaceae) on pathogenic bacteria from land-based sources. Appl Ecol Environ Res. 2008;16:3767–81 https://doi.org/10.15666/AEER%2F1604_37673781.

    Article  Google Scholar 

  39. Maria D, Luziene AC, Emily C, Bruno O, M’arcia V, Nunes C, Renata M. Bioactivity flavonoids from roots of Euphorbia tirucalli L. Phytochem. Lett. 2021;41:186–192. https://doi.org/10.1016/j.phytol.2020.10.017.

Download references

Acknowledgements

The authors acknowledge the NRF-TWAS, the Tshwane University of Technology and Rhodes University.

Human and animal rights

No human/animals were used in current study.

Funding

This work was financially supported by South Africa, through the National Research Foundation Research grant under grant numbers 190403426633, Tshwane University of Technology, South Africa. The antimicrobial research reported in this publication was supported by the South African Medical Research Council with funds received from the South African Nation Department of Health, and the UK Medical Research Council with funds received from the UK Government’s Newton Fund.

Author information

Authors and Affiliations

  1. Department of Chemistry, Tshwane University of Technology, Pretoria, 0001, South Africa

    Douglas Kemboi & Vuyelwa Jacqueline Tembu

  2. Department of Chemistry, Rhodes University, Makhanda (Grahamstown), 6140, South Africa

    Douglas Kemboi & Rui W. M. Krause

  3. Royal Botanic Gardens Kew, Kew Green, Richmond, Surrey, TW9 3AE, UK

    Moses K. Langat

  4. Pharmaceutical Sciences Department, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, 0204, South Africa

    Xavier Siwe-Noundou

  5. Department of Biochemistry and Microbiology, Rhodes University, Makhanda (Grahamstown),, 6140, South Africa

    Michelle Louise Isaacs

Authors
  1. Douglas Kemboi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Moses K. Langat
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xavier Siwe-Noundou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rui W. M. Krause
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michelle Louise Isaacs
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Vuyelwa Jacqueline Tembu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conceptualization, D.K. methodology, D.K.; resources, X.S.N, R.W.M.K, data curation, V.J.T, M.K.L.; Bioassay analysis, M.L.I.; writing original draft preparation, D.K.; writing review and editing, M.K.L, X.S.N, V.J.T.; supervision, V.J.T. All authors have read and agreed to the published version of the manuscript.

Corresponding authors

Correspondence to Douglas Kemboi or Vuyelwa Jacqueline Tembu.

Ethics declarations

Ethics approval and consent to participate

All the methods used in this study were performed in accordance with relevant guidelines and regulation as approved by the research ethics committee. The permission to collect the Euphorbia grandicornis Blanc was granted by the South African National Biodiversity Institute (SANBI).

Consent for publication

Not applicable.

Competing interests

The authors declare no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Supplementary Materials.

The following are available online alongside Appendix 1–12, Appendix LC-MS1-LCMS6, Table S1. 13C (δc) (100.6 MHZ) NMR data for compounds 1-11 in CDCl3, Table S2. 1H (δH, m, (J, Hz) NMR (400 MHZ) data for compounds 1–4 in CDCl3.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kemboi, D., Langat, M.K., Siwe-Noundou, X. et al. In vitro antibacterial and cytotoxic effects of Euphorbia grandicornis Blanc chemical constituents. BMC Complement Med Ther 22, 90 (2022). https://doi.org/10.1186/s12906-022-03571-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12906-022-03571-8

Keywords

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us